FOR PREVIEW ONLY (Print)

Prediman K. Shah, MD

Director, Oppenheimer Atherosclerosis Research Center

Director, Atherosclerosis Prevention and Management Center

Shapell and Webb Family Chair in Clinical Cardiology

Professor, Medicine

Prediman K. Shah, MD

Director, Oppenheimer Atherosclerosis Research Center

Director, Atherosclerosis Prevention and Management Center

Shapell and Webb Family Chair in Clinical Cardiology

Professor, Medicine

  • IM/Cardiology

Angina

Aortic Aneurysms

Aortic Dissections

Aortic Regurgitation

Aortic Stenosis

Arrhythmias (Irregular Heartbeat, Heart Rhythm Disorders)

Atrial Fibrillation

Atrial Septal Defect

Cardiomyopathy

Chest Pains

Cholesterol Testing

Congenital Heart Diseases

Coronary Artery Disease (CAD)

Coronary Calcium Scans

EKG (Electrocardiograms)

Heart Attack (Myocardial Infarction)

Heart Murmurs

Marfan's Syndrome

Myocarditis

Peripheral Vascular Disease

The research of Prediman K. Shah, MD, focuses on molecular mechanisms of atherosclerosis, and novel therapeutic strategies to prevent and reverse atherosclerosis.

  • Internship: Mount Sinai Hospital, 1972
  • Residency: Montefiore Medical Center, 1974
  • Fellowship: Montefiore Medical Center, 1976

View CV as a PDF

  • Master of American College of Cardiology, 2015
  • Elliot Rapaport Cardiologist of the Year, California-ACC, 2014
  • Distinguished Scientific Achievement Award, American College of Cardiology, 2012
  • James B Herrick Award, American Heart Association, 2008
  • Annual Laennec Society Lecture, American Heart Association, 2008
  • Pioneer in Medicine Award, Cedars-SInai, 2007
  • Lifetime Achievement Award, LA Chapter of American Heart Association, 2002
  • Gifted Teacher Award, American College of Cardiology, 2001
  • Dean's Award for Excellence in Teaching, UCLA, 1990
  • Shapell and Webb Family Chair in Clinical Cardiology, Cedars-Sinai, 1990

Show moreShow less

  • Sharifi BG, Zeng Z, Wang L, Song L, Chen H, Qin M, Sierra-Honigmann MR, Wachsmann-Hogiu S, Shah PK. Pleiotrophin induces transdifferentiation of monocytes into functional endothelial cells. Arterioscler Thromb Vasc Biol. 2006;26(6):1273-1280.
  • Wang L, Sharifi BG, Pan T, Song L, Yukht A, Shah PK. Bone marrow transplantation shows superior atheroprotective effects of gene therapy with apolipoprotein A-I Milano compared with wild-type apolipoprotein A-I in hyperlipidemic mice. J Am Coll Cardiol. 2006;48(7):1459-1468.
  • Michelsen KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM, Akira S, Rajavashisth TB, Arditi M. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci U.S.A. 2004;101(29):10679-10684.
  • Chyu KY, Shah PK. Choking off plaque neovascularity: a promising atheroprotective strategy or a double-edged sword? Arterioscler Thromb Vasc Biol. 2007;27(5):993-995.
  • Shah PK. Innate immune pathway links obesity to insulin resistance. Circ Res. 2007;100(11):1531-1533.
  • Fredrikson GN, Schiopu A, Berglund G, Alm R, Shah PK, Nilsson J. Autoantibody against the amino acid sequence 661-680 in apo B-100 is associated with decreased carotid stenosis and cardiovascular events. Atherosclerosis. 2007;194(2):e188-192.
  • Honjo T, Chyu KY, Dimayuga PC, Yano J, Lio WM, Trinidad P, Zhao X, Zhou J, Chen S, Cercek B, Arditi M, Shah PK. ApoB-100-related peptide vaccine protects against angiotensin II-induced aortic aneurysm formation and rupture. J Am Coll Cardiol. 2015;65(6):546-556.

Show moreShow less

English / Hindi / Urdu

Make an Appointment

Call

1-800-CEDARS-1

(1-800-233-2771)

Available 24 Hours A Day

or

Many of the physicians who have medical staff privileges to practice medicine at Cedars-Sinai Medical Center are independent physicians, and not employees or agents of the hospital. These independent physicians bill separately for their services. You should contact your physician to determine their status and billing practices.

Send Email to Prediman K. Shah, MD